Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-375-3 | CAS number: 120-18-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 50 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 1
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4 167 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 24
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
Workers - Hazard for the eyes
Additional information - workers
Local effects
Reliable animal studies were available to assess the local effects of naphthalene-2-sulfonic acid. One mg of 80% naphthalene-2-sulfonic acid caused corrosion (full-thickness necrosis) on rabbit skin after 20 h exposure under occlusive conditions; strong irritant effects were seen after 15 min of exposure. Corrosive effects were also observed in an eye irritation study where 0.05 mL of naphthalene-2-sulfonic acid were instilled in the eyes of rabbits (BASF AG 1972). Therefore, a classification of R 34/ skin corrosion Cat. 1C is warranted for naphthalene-2 -sulfonic acid. However, a quantitative approach of an No-effect-level could not be made based on these studies. Due to low vapour pressure, no relevant exposure of the respiratory tract is expected.
Short-term exposure - systemic effects
There were no adverse systemic effects observed after short-term exposure. The mortalities seen in a acute toxicity study in rats after administration of 16% aqueous solution with naphthalene-2-sulfonic acid per gavage, leading to a LD50 of 1400 mg/kg bw (BASF AG 1972) are considered as consequence of local corrosive effects in the stomach as indicated by LD50 values above 5000 mg/kg bw with sodium salts of napthalene-1 -sulfonic acid and napthalene-2 -sulfonic acid. Therefore, a DNEL for short-term systemic effects is not warranted.
Long-term exposure - systemic effects
No relevant systemic toxic effects were observed in an extended one-generation study with the potassium salt of naphthalenesulfonic acids in rats. The test substance was applied for 15 weeks to parental rats in doses up to 1000 mg/kg bw/d. This value was therefore considered as lowest NOAEL for subchronic oral administration. This value was modified to get the correct starting point for the dermal and inhalative DNEL derivation.
For the oral-dermal extrapolation, a factor of 0.01 is used, based on the result of the ex vivo dermal absorption study with naphthalenesulfonic acid, sodium salt (Goldwell 1997). Here, 1% the test substance permeates through pig skin within 24 hours; the correct starting point was therefore 100,000 mg/kg bw/d. The low potential for dermal absorption is applicable only for intact skin. Regarding the corrosive effects of naphthalene-2 -sulfonic acid, it is considered that repeated dermal exposure to naphthalene-2-sulfonic acid leads to at least partial destruction of the skin tissue and, subsequently, to an increase of dermal absorption. However, this has to be considered as a secondary effect of the corrosive properties of naphthalene-2 -sulfonic acid; this hazard is assessed to be sufficiently covered by the qualitative assessment of the local effects.
Discussion of the applied assessment factors (for the dermal exposure; ECETOC 2003, 2010):
Remaining differences: 1
Interspecies factor: 4 (rat)
Intraspecies factor: 3 (worker)
Exposure duration: 2 (subchronic to chronic)
Dose response: 1
Data base quality: 1
Total assessment factor (AF) = 24
The DNEL for long-term dermal exposure, systemic effects is therefore considered to be (100,000/24 =) 4167 mg/kg bw/d.
For the oral-inhalation extrapolation, a default factor of 1 is used. Additionally, the DNEL was calculated by dividing the NOAEL of 1000 mg/kg bw/d with 0.38 m3/kg bw and then multiplying with 6.7 m3/ 10 m3 70 kg as described in the REACH guidance document R8 (2008; p.65) following the allometric scaling principle; the correct starting point was therefore 1763 mg/m3/d for the inhalative pathway.
Discussion of the applied assessment factors (for the inhalative exposure; ECETOC 2003, 2010):
Remaining differences: 1
Intraspecies factor: 3 (worker)
Exposure duration: 2 (subchronic to chronic)
Dose response: 1
Data base quality: 1
Total assessment factor (AF) = 6
The DNEL for long-term inhalative exposure, systemic effects is therefore considered to be (1763/6 =) 294 mg/m3/d.
However, the substance contains ca. 3.3% of naphthalene (CAS # 91-20-3). Therefore, as a worst-case assumption for repeated dose toxicity effects by inhalation of naphthalenesulfonic acids, the European long term limit value of naphthalene, 50 mg/m3/d, is considered as the most sensitive and most reliable DNEL for systemic effects after long-term inhalative exposure to workers.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 10.6 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 4.7
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 2 500 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 25 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
General Population - Hazard for the eyes
Additional information - General Population
Local effects
See discussion above (DNEL for worker)
Short-term exposure - systemic effects
See discussion above (DNEL for worker)
Long-term exposure - systemic effects
For the origin of the basic NOAEL of 1000 mg/kg bw/d see discussion above (DNEL for worker). For consumer, following adoptions were made in contrast to the worker DNELs:
Additionally, a DNEL has to be determined for oral exposure.
Discussion of the applied assessment factors (for oral and dermal eposure pathways; ECETOC 2003, 2010):
Remaining differences: 1
Interspecies factor: 4 (rat)
Intraspecies factor: 5 (consumer)
Exposure duration: 2 (subchronic to chronic)
Dose response: 1
Data base quality: 1
Total assessment factor (AF) = 40
The DNEL for long-term dermal exposure, systemic effects is therefore considered to be (100,000/40=) 2500 mg/kg bw/d.
The DNEL for long-term oral exposure, systemic effects is therefore considered to be (1000/40=) 25 mg/kg bw/d.
Here, the inhalative DNEL was calculated by dividing the NOAEL of 1000 mg/kg bw/d with 1.15 m3/kg bw as described in the REACH guidance document R8 (2008; p.64) following the allometric scaling principle; the correct starting point was therefore 870 mg/m3/d for the inhalative pathway.
Discussion of the applied assessment factors (for the inhalative exposure; ECETOC 2003, 2010):
Remaining differences: 1
Intraspecies factor: 5 (consumer)
Exposure duration: 2 (subchronic to chronic)
Dose response: 1
Data base quality: 1
Total assessment factor (AF) = 10
The DNEL for long-term inhalative exposure, systemic effects is therefore considered to be (870/10=) 87 mg/m3/d.
However, the substance contains ca. 3.3% of naphthalene (CAS # 91-20-3) (see DNEL for worker). Therefore, as a worst-case assumption for repeated dose toxicity effects by inhalation of naphthalenesulfonic acids, based on the European long term limit value of naphthalene (50 mg/m3/d) following assessment factors were used to derive the DNEL for systemic effects after long-term inhalative exposure to the general population.
Discussion of the applied assessment factors (for the inhalative exposure; ECETOC 2003, 2010):
Remaining differences: 1
Intraspecies factor: 1.7 (worker to consumer)
Respiratory volume: 0.67 (10 m3/8 h to 6.7 m3/8 h)
Exposure duration: 4.2 (8 to 24 h, 5 to 7 d)
Dose response: 1
Data base quality: 1
Total assessment factor (AF) = 4.7
The DNEL for long-term inhalative exposure, systemic effects, based on repeated dose toxicity effects by inhalation
of naphthalene, is therefore considered to be (50/4.7=) 10.6 mg/m3/d. This is considered as most sensitive value and is therefore used to derive the most reliable DNEL for systemic effects after long-term inhalative exposure to the general population.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.